Edwards Lifesciences Corporation Analysis
| Analyst Ratings |
|
Average Target Price
|
91.50
|
|
Average Rating
|
4.08
|
|
# Strong Buys
|
10
|
|
# Buys
|
6
|
|
# Holds
|
8
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
0.62
|
0.61
|
-0.01
|
-1.61%
|
|
2022-06-30
|
0.64
|
0.63
|
-0.01
|
-1.56%
|
|
2022-03-31
|
0.57
|
0.60
|
0.03
|
5.26%
|
|
2021-12-31
|
0.55
|
0.51
|
-0.04
|
-7.27%
|
|
2021-09-30
|
0.53
|
0.54
|
0.01
|
1.89%
|
|
2021-06-30
|
0.56
|
0.64
|
0.08
|
14.29%
|
|
2021-03-31
|
0.47
|
0.54
|
0.07
|
14.89%
|
|
2020-12-31
|
0.53
|
0.50
|
-0.03
|
-5.66%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
1.84
|
|
2021-12-31
|
2.23
|
|
2020-12-31
|
1.85
|
|
2019-12-31
|
1.86
|
|
2018-12-31
|
2.38
|
|
2017-12-31
|
3.80
|
|
2016-12-31
|
2.90
|
|
2015-12-31
|
2.29
|
|
2014-12-31
|
1.75
|
|
2013-12-31
|
1.57
|
|
2012-12-31
|
1.35
|
|
2011-12-31
|
1.02
|
|
2010-12-31
|
0.93
|
|
2009-12-31
|
0.77
|
|
2008-12-31
|
0.65
|
|
2007-12-31
|
0.54
|
|
2006-12-31
|
0.53
|
|
2005-12-31
|
0.50
|
|
2004-12-31
|
0.43
|
|
2003-12-31
|
0.40
|
|
2002-12-31
|
0.35
|
|
2001-12-31
|
0.26
|
|
2000-12-31
|
0.20
|